FDA Approved: LAMZEDE — Original Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved Lamzede (velmanase alfa-tycv) from Chiesi USA as an original Biologics License Application for the treatment of alpha-mannosidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamzede (velmanase alfa)

Snippet

ORIG AP for LAMZEDE (VELMANASE ALFA-TYCV)